Clinical Trial: Safety, Tolerability, and Pharmacokinetic Study of TV-44749 in Chinese Patients With Schizophrenia
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Schizophrenia
Study Type: INTERVENTIONAL
Official Title: A Phase 1, Single Dose, Parallel Cohort Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TV-44749, Olanzapine for Extended-Release Injectable Suspension for Subcutaneous Use, in Chi
Brief Summary:
Primary Objective:To evaluate the safety and tolerability of single doses of TV-44749 for subcutaneous (sc) use in Chinese participants with schizophrenia.Secondary Objectives:To evaluate the pharmacokinetics (PK) of single doses of TV-44749 administered sc.To evaluate the pharmacokinetics of oral olanzapine tablets following multiple dose administration.To monitor the safety and tolerability of multiple doses of oral olanzapine tablets given in the study.
Read more